October 27, 2022 to October 28, 2022
Hilton Miami Airport Blue Lagoon, Miami, Florida
Information and Registration:
As valvular heart disease and structural heart treatments become more integral within cardiology, providers will rely on the diagnosis and treatment of disease using transcatheter/nonsurgical therapy.
The 39th Annual Echocardiography and Structural Heart Symposium – formerly known as the Echocardiography Symposium – will include successful topics from years past that focus on current guidelines for the evaluation of core topics within echocardiography, such as cardiac structure, cardiac function and hemodynamics assessment.
In addition, the internationally renowned faculty experts will address the latest developments, cutting-edge technologies and future directions of structural heart disease assessment, treatment options and advanced cardiac imaging.
These discussions will include advanced echocardiography imaging techniques (3-D, Strain, CT and TEE) and valve repair approaches (TAVR, mitral valve repair devices, left atrial appendage occlusion devices, paravalvular closure and alcohol septal ablation). Treatment focus will be on aortic, mitral and tricuspid valves and interatrial septum valvular heart disease, as well as specific patient populations, including those with cancer, atrial fibrillation, valvular heart disease and hypertrophic cardiomyopathy. Current controversies speak to indications and contraindications for various diagnostic and treatment approaches.
This year’s expanded focus will be of special interest to anesthesiologists, cardiologists, ED physicians, critical care physicians, sonographers and medical professionals interested in echocardiography and the newest advances in diagnosis and treatment of structural heart disease.
MORE INFORMATION AND REGISTER >>